Restore-1 clinical trial uses steam to refresh part of the small intestine in an effort to restore natural blood-sugar controlContinue reading
Author Archive: AZBio
ASU Health’s alliance with HonorHealth to benefit researchers, students — and Arizona residents who never step foot in a classroom
As primary clinical affiliate for the John Shufeldt School of Medicine and Medical Engineering, HonorHealth opens up opportunities for improving care for the stateContinue reading
TGen, City of Hope study surveys dysfunctional gene splicing in metastatic kidney disease
Aberrant splicing helps predict therapeutic responses in patients with metastatic renal cell
J. Craig Venter, genomics pioneer, dies at 79
La Jolla, California—April 29, 2026—The J. Craig Venter Institute (JCVI) announced that J. Craig Venter, Ph.D., the Institute’s founder, board chair, and chief executive officer, died today in San Diego following a brief hospitalization for unexpected side effects that arose from treatment of recently diagnosed cancer.
Dr. Venter was a visionary scientific leader whose work helped define modern genomics and launch the field of synthetic biology. He drove scientific and technological change by building interdisciplinary teams, pushing for bold ideas and faster methods, and insisting that discovery should translate into real-world impact. He was also a fierce advocate for robust federal science funding and for partnerships that accelerate progress across government, academia, and industry.Continue reading
7 Health Sciences faculty and staff members receive Convergence Awards
The annual awards are one of the university’s highest recognitions for interdisciplinary research achievement and honor the faculty, staff and external partners whose work exemplifies the U of A’s commitment to inquiry, innovation and societal impact. The recognition program, which is hosted by the Office of Research and Partnerships, highlights those advancing transformative research and creative activity across disciplines, sectors and communities.Continue reading
University of Arizona innovation drives $459.7 million in annual economic impact for Arizona
New independent analysis finds Tech Launch Arizona supported 3,070 jobs in FY 2025 and projects $2.5B more in economic output through 2030.Continue reading
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Prescription Drug User Fee Act (PDUFA) date set for August 25, 2026Continue reading
C-Path Podcast Highlights Bold Ideas in Drug Development
The Critical Path Institute Podcast started connecting the dots for health innovators around the world one year ago. What started as a bold idea to bring the world of drug development, regulatory science, and clinical research to life through conversation has grown into a rich library of episodes covering everything from clinical outcome assessments and pediatric drug development to rare disease research and the power of data collaboration. Continue reading